A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants
Clinical trial NCT03933488 · COMPLETED
Trial details
- NCT number
- NCT03933488
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2020-03-29
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.